Global Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

According to APO Research, The global Vaccine Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.

Vaccine Adjuvants segment by Company

GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Vaccine Adjuvants segment by Type

Aluminum Adjuvant
Emulsions Adjuvant
Others
Vaccine Adjuvants segment by Application

Human Vaccine
Veterinary Vaccine
Vaccine Adjuvants segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccine Adjuvants market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Vaccine Adjuvants Market Size, 2019 VS 2023 VS 2030
1.3 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2019-2030)
1.4 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
1.5 Global Vaccine Adjuvants Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Vaccine Adjuvants Market Dynamics
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 Vaccine Adjuvants Market by Manufacturers
3.1 Global Vaccine Adjuvants Revenue by Manufacturers (2019-2024)
3.2 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
3.3 Global Vaccine Adjuvants Average Sales Price by Manufacturers (2019-2024)
3.4 Global Vaccine Adjuvants Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
3.7 Global Vaccine Adjuvants Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
3.8.3 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
4 Vaccine Adjuvants Market by Type
4.1 Vaccine Adjuvants Type Introduction
4.1.1 Aluminum Adjuvant
4.1.2 Emulsions Adjuvant
4.1.3 Others
4.2 Global Vaccine Adjuvants Sales by Type
4.2.1 Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Adjuvants Sales by Type (2019-2030)
4.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.3 Global Vaccine Adjuvants Revenue by Type
4.3.1 Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
4.3.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
5 Vaccine Adjuvants Market by Application
5.1 Vaccine Adjuvants Application Introduction
5.1.1 Human Vaccine
5.1.2 Veterinary Vaccine
5.2 Global Vaccine Adjuvants Sales by Application
5.2.1 Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Vaccine Adjuvants Sales by Application (2019-2030)
5.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.3 Global Vaccine Adjuvants Revenue by Application
5.3.1 Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
5.3.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
6 Global Vaccine Adjuvants Sales by Region
6.1 Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Vaccine Adjuvants Sales by Region (2019-2030)
6.2.1 Global Vaccine Adjuvants Sales by Region (2019-2024)
6.2.2 Global Vaccine Adjuvants Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Vaccine Adjuvants Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Vaccine Adjuvants Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Vaccine Adjuvants Revenue by Region
7.1 Global Vaccine Adjuvants Revenue by Region
7.1.1 Global Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Vaccine Adjuvants Revenue by Region (2019-2024)
7.1.3 Global Vaccine Adjuvants Revenue by Region (2025-2030)
7.1.4 Global Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Vaccine Adjuvants Revenue (2019-2030)
7.2.2 North America Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Vaccine Adjuvants Revenue (2019-2030)
7.3.2 Europe Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Vaccine Adjuvants Revenue (2019-2030)
7.4.2 Asia-Pacific Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Vaccine Adjuvants Revenue (2019-2030)
7.5.2 LAMEA Vaccine Adjuvants Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 GSK
8.1.1 GSK Comapny Information
8.1.2 GSK Business Overview
8.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 GSK Vaccine Adjuvants Product Portfolio
8.1.5 GSK Recent Developments
8.2 CSL Limited
8.2.1 CSL Limited Comapny Information
8.2.2 CSL Limited Business Overview
8.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
8.2.5 CSL Limited Recent Developments
8.3 Croda
8.3.1 Croda Comapny Information
8.3.2 Croda Business Overview
8.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Croda Vaccine Adjuvants Product Portfolio
8.3.5 Croda Recent Developments
8.4 SEPPIC
8.4.1 SEPPIC Comapny Information
8.4.2 SEPPIC Business Overview
8.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
8.4.5 SEPPIC Recent Developments
8.5 Novavax
8.5.1 Novavax Comapny Information
8.5.2 Novavax Business Overview
8.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Novavax Vaccine Adjuvants Product Portfolio
8.5.5 Novavax Recent Developments
8.6 SPI Pharma
8.6.1 SPI Pharma Comapny Information
8.6.2 SPI Pharma Business Overview
8.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
8.6.5 SPI Pharma Recent Developments
8.7 Phibro
8.7.1 Phibro Comapny Information
8.7.2 Phibro Business Overview
8.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Phibro Vaccine Adjuvants Product Portfolio
8.7.5 Phibro Recent Developments
8.8 SDA BIO
8.8.1 SDA BIO Comapny Information
8.8.2 SDA BIO Business Overview
8.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
8.8.5 SDA BIO Recent Developments
8.9 Invivogen
8.9.1 Invivogen Comapny Information
8.9.2 Invivogen Business Overview
8.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Invivogen Vaccine Adjuvants Product Portfolio
8.9.5 Invivogen Recent Developments
8.10 Tj Kaiwei
8.10.1 Tj Kaiwei Comapny Information
8.10.2 Tj Kaiwei Business Overview
8.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
8.10.5 Tj Kaiwei Recent Developments
8.11 OZ Biosciences
8.11.1 OZ Biosciences Comapny Information
8.11.2 OZ Biosciences Business Overview
8.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
8.11.5 OZ Biosciences Recent Developments
8.12 Brenntag Biosector
8.12.1 Brenntag Biosector Comapny Information
8.12.2 Brenntag Biosector Business Overview
8.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
8.12.5 Brenntag Biosector Recent Developments
8.13 MVP Laboratories
8.13.1 MVP Laboratories Comapny Information
8.13.2 MVP Laboratories Business Overview
8.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
8.13.5 MVP Laboratories Recent Developments
8.14 Zhuoyue
8.14.1 Zhuoyue Comapny Information
8.14.2 Zhuoyue Business Overview
8.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
8.14.5 Zhuoyue Recent Developments
8.15 Aphios
8.15.1 Aphios Comapny Information
8.15.2 Aphios Business Overview
8.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 Aphios Vaccine Adjuvants Product Portfolio
8.15.5 Aphios Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Vaccine Adjuvants Value Chain Analysis
9.1.1 Vaccine Adjuvants Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Vaccine Adjuvants Production Mode & Process
9.2 Vaccine Adjuvants Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Vaccine Adjuvants Distributors
9.2.3 Vaccine Adjuvants Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings